MW33

MW33 Uses, Dosage, Side Effects, Food Interaction and all others data.

MW33 is a recombinant fully human antibody to SARS-CoV-2. This antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A Clinical Study to Evaluate MW33 Injection).

Trade Name MW33
Generic MW33
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
MW33
MW33

How MW33 works

The antibody MW33 targets the S protein epitope and is currently being investigated against COVID-19.

Innovators Monograph

You find simplified version here MW33


*** Taking medicines without doctor's advice can cause long-term problems.
Share